(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.
############
Story Source: Materials provided by Scienmag
PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey
Please login to join discussion
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
